Physician profile
Scott Johnson
NPI 1821438375
$10,201.13
in general payments reported to CMS, 2019-2025
9 companies · $1,326 in 2025
The $1,326 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2021: $1,733 · 2022: $4,956 · 2023: $576 · 2024: $1,376 · 2025: $1,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $1,019 · Travel and Lodging: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $1,019.17 |
| Travel and Lodging | $258.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $8,063.28 | 2021-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Philips North America LLC | $1,290.71 | 2021 | |
| Medtronic Vascular, INC. | $174.18 | 2019 | |
| Intuitive Surgical, INC. | $170.91 | 2021 | |
| Davol INC. | $165.56 | 2024 | Arista Ah Flexitip |
| Abbott Laboratories | $156.23 | 2022 | |
| Edwards Lifesciences Corporation | $120.09 | 2021 | |
| Ethicon US, LLC | $38.78 | 2019 | |
| Livanova USA, INC. | $21.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.